Bracebridge Capital, LLC Aquestive Therapeutics, Inc. Transaction History
Bracebridge Capital, LLC
- $646 Million
- Q4 2024
A detailed history of Bracebridge Capital, LLC transactions in Aquestive Therapeutics, Inc. stock. As of the latest transaction made, Bracebridge Capital, LLC holds 459,216 shares of AQST stock, worth $1.45 Million. This represents 0.25% of its overall portfolio holdings.
Number of Shares
459,216
Previous 428,571
7.15%
Holding current value
$1.45 Million
Previous $2.13 Million
23.85%
% of portfolio
0.25%
Previous 1.92%
Shares
2 transactions
Others Institutions Holding AQST
# of Institutions
120Shares Held
43.3MCall Options Held
504KPut Options Held
148K-
Bratton Capital Management, L.P. Fort Worth, TX9.81MShares$30.9 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.45MShares$17.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.35MShares$13.7 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY2.63MShares$8.28 Million1.54% of portfolio
-
Franklin Resources Inc San Mateo, CA2.13MShares$6.72 Million0.0% of portfolio
About Aquestive Therapeutics, Inc.
- Ticker AQST
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,350,700
- Market Cap $168M
- Description
- Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...